Impact of skin cancer screening on the incidence of advanced melanoma and melanoma mortality – A pilot project for a case-control study in the setting of the German nationwide skin cancer screening

• Conditions: C43; Malignant melanoma of skin

• Registration Number: DRKS00012831
• Lead Sponsor: Institut für Sozialmedizin und Epidemiologie, Universität zu Lübeck

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-11-14
• Study Completion: 2018-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

Inclusion criteria for cases: Primary diagnosis of invasive cutaneous melanoma (ICD-10: C43);
Stage IV disease at time of recruitment (irrespective of stage at diagnosis);
Date of first diagnosis in 2013 or later;
Age at first diagnosis =37 years;
Informed written consent for study participation.
Inclusion criteria for controls: Age, sex and region matched to the corresponding case; Informed written consent for study participation.

Exclusion Criteria

Exclusion criteria of cases: Age at first diagnosis 36 years and younger;
Second melanoma;
Inability to take part in the questionnaire or telephone interview;
Inability to take part in skin cancer screening before melanoma diagnosis (e.g. living abroad);
No informed written consent.
Exclusion criteria of controls: Age, sex, and region not compatible with the corresponding case;
Inability to take part in the questionnaire or telephone interview;
Inability to take part in skin cancer screening before melanoma diagnosis (e.g. living abroad);
No informed written consent.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility of a case-control study for evaluating effects of skin cancer screenig.